- Home
- VIRC vs PBYI Comparison
VIRC vs PBYI Comparison
Compare VIRC & PBYI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VIRC
- PBYI
- Stock Information
- Founded
- VIRC 1950
- PBYI 2010
- Country
- VIRC United States
- PBYI United States
- Employees
- VIRC N/A
- PBYI N/A
- Industry
- VIRC Industrial Specialties
- PBYI Biotechnology: Pharmaceutical Preparations
- Sector
- VIRC Consumer Discretionary
- PBYI Health Care
- Exchange
- VIRC Nasdaq
- PBYI Nasdaq
- Market Cap
- VIRC 158.2M
- PBYI 154.1M
- IPO Year
- VIRC N/A
- PBYI N/A
- Fundamental
- Price
- VIRC $9.46
- PBYI $2.98
- Analyst Decision
- VIRC Buy
- PBYI Strong Buy
- Analyst Count
- VIRC 1
- PBYI 1
- Target Price
- VIRC $19.00
- PBYI $7.00
- AVG Volume (30 Days)
- VIRC 66.9K
- PBYI 386.8K
- Earning Date
- VIRC 04-11-2025
- PBYI 05-01-2025
- Dividend Yield
- VIRC 1.06%
- PBYI N/A
- EPS Growth
- VIRC N/A
- PBYI 37.78
- EPS
- VIRC 1.53
- PBYI 0.62
- Revenue
- VIRC $280,375,000.00
- PBYI $230,468,000.00
- Revenue This Year
- VIRC $6.43
- PBYI N/A
- Revenue Next Year
- VIRC $2.38
- PBYI $3.27
- P/E Ratio
- VIRC $6.15
- PBYI $4.83
- Revenue Growth
- VIRC 5.68
- PBYI N/A
- 52 Week Low
- VIRC $9.08
- PBYI $2.23
- 52 Week High
- VIRC $18.50
- PBYI $6.06
- Technical
- Relative Strength Index (RSI)
- VIRC 35.68
- PBYI 39.26
- Support Level
- VIRC $9.43
- PBYI $3.14
- Resistance Level
- VIRC $9.71
- PBYI $3.18
- Average True Range (ATR)
- VIRC 0.32
- PBYI 0.20
- MACD
- VIRC -0.00
- PBYI -0.06
- Stochastic Oscillator
- VIRC 15.65
- PBYI 4.38
About VIRC Virco Manufacturing Corporation
Virco Manufacturing Corp is engaged in designing, production and distributing quality furniture for the commercial and education markets. The company manufactures an assortment of products, including mobile tables, mobile storage equipment, desks, computer furniture, chairs, and activity tables, folding chairs, and folding tables. Its primary furniture lines are constructed of tubular metal legs and frames, combined with wood and plastic tops, plastic seats and backs, upholstered seats and backs, and upholstered rigid polyethylene and polypropylene shells.
About PBYI Puma Biotechnology Inc
Puma Biotechnology Inc is a biopharmaceutical company that develops and commercializes innovative products to enhance cancer care and improve treatment outcomes for patients. It is currently commercializing NERLYNX, an oral version of neratinib, for the treatment of HER2-positive breast cancer. Also it develops alisertib. Alisertib is a selective, small-molecule inhibitor of aurora kinase A that is designed to disrupt mitosis leading to apoptosis of rapidly proliferating tumor cells that are dependent on aurora kinase A.